✦ LIBER ✦

Intra-arterial administration of methotrexate, Adriamycin, and cisplatin as neoadjuvant chemotherapy for bladder cancer

✍ Scribed by Manabu Kuriyama; Yoshito Takahashi; Yukihiro Nagatani; Ikuo Shinoda; Naoki Yamamoto; Tsukasa Nagai; Kazuya Ueno; Toshimi Takeuchi; Shinichi Maeda; Kazutoshi Isogai; Yukimichi Kawada

Publisher: Springer
Year: 1992
Tongue: English
Weight: 343 KB
Volume: 30
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00686932

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of systemic chemotherapy with

Evaluation of systemic chemotherapy with methotrexate, vinblastine, Adriamycin, and cisplatin for advanced bladder cancer

✍ Toshihiko Kotake; Hideyuki Akaza; Shigoe Isaka; Susumu Kagawa; Kenkichi Koiso; T 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 469 KB

Neoadjuvant gemcitabine and cisplatin ch

Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder

✍ Emil Scosyrev; Edward M. Messing; Edwin van Wijngaarden; Derick R. Peterson; Dee 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Use of methotrexate, vinblastine, adriam

Use of methotrexate, vinblastine, adriamycin, and cisplatin in combination with radiation and hyperthermia as neo-adjuvant therapy for bladder cancer

✍ Sumio Noguchi; Yoshinobu Kubota; Takeshi Miura; Taro Shuin; Masahiko Hosaka 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 313 KB

Phase II study of docetaxel, capecitabin

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer

✍ Yen-Shen Lu; Dar-Ren Chen; Ling-Min Tseng; Dah-Cherng Yeh; Shou-Tung Chen; Chia- 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Treatment options for muscle-invasive ur

Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin : Report of Southwest Oncology Group Trial 8733

✍ Celestia S. Higano; Catherine M. Tangen; Wael A. Sakr; James Faulkner; Saul E. R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract ## BACKGROUND. Many patients with invasive urothelial cell cancer are poor candidates for cisplatin‐based chemotherapy, and many are high risk for cystectomy. Southwest Oncology Group Trial 8733 was designed to address treatment for such patients. ## METHODS. Eligible patients had pr